Newsletter

Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria market expects the entry of novel treatment options to address a life-threatening disease of the blood.
Paroxysmal Nocturnal Hemoglobinuria Newsletter

More Whitepapers / Newsletters

ASCO: Evolution of Precision Medicine
Let Us Hear From ASCO: Evoluti...

Past decades have witnessed a shift in the focus of researchers and pharma companies towards tailoring the treatment approach and regiment cancer patients are administered. Unlike traditional chemothe...

Chronic Inflammatory Demyelinating Polyneuropathy Market
Chronic Inflammatory Demyelina...

A rare neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms, Chronic inflammatory demyelinating polyneuropathy (CIDP) is a result of the damag...

The Ophthalmic Drug Delivery Therapeutics For Retinal Disorders Whitepaper
The Ophthalmic Drug Delivery T...

Delivery of therapeutics to the human eye is among the most interesting endeavours a formulator can take on, but also one of the most challenging. The anatomy and chemical make-up of the eye make it h...

Induced Pluripotent Stem Cells (IPSCs) Research And Development
Induced Pluripotent Stem Cells...

IPSCs have enormous applications in the field of regenerative medicine, disease modelling, and drug discovery. For the development of regenerative medicine, somatic cells from a diseased patient are u...

HIV-Associated Lipodystrophy Market
HIV-Associated Lipodystrophy

HIV-associated lipodystrophy (HAL), is a condition characterized by the redistribution of adipose tissue. It can be due to several reasons, however, a significant amount of research done links its cau...